Quality of life in patients with alopecia areata: A hospital-based cross-sectional study

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 5, 2016, Pages 840-846

  Jankovic, S ^a   Peric, J ^b   Maksimovic, N ^a   Cirkovic, A ^a   Marinkovic, J ^a   Jankovic, J ^a   Reljic, V ^b   Medenica, L ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CROSS-SECTIONAL STUDY; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SERBIAN (CITIZEN); SEVERITY OF ALOPECIA TOOL; SHORT FORM 36; SKINDEX 29; SOCIAL INTERACTION; ADOLESCENT; HOSPITAL; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; ALOPECIA AREATA; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 84949981020     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13520     Document Type: Article

References (34)

1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ III,. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995; 70: 628-633.
2. Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR,. Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol 2014; 134: 1141-1142.
3. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A,. Alopecia areata. Int J Dermatol 2007; 46: 121-131.
4. Masmoudi J, Sellami R, Ouali U, et al,. Quality of life in alopecia areata: a sample of Tunisian patients. Dermatol Res Pract 2013; 2013: 983804.
5. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, et al,. Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol 2010; 130: 2830-2833.
6. Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E,. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol 2009; 23: 572-573.
7. Al-Mutairi N, Eldin ON,. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol 2011; 77: 489-493.
8. Olsen EA, Hordinsky MK, Price VH, et al,. Alopecia areata investigational assessment guidelines-Part II". J Am Acad Dermatol 2004; 51: 440-447.
9. Hunt N, McHale S,. The psychological impact of alopecia. BMJ 2005; 331: 951-953.
10. Hordinsky M, Ericson M,. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc 2004; 9: 73-78.
11. Martinez-Mir A, Zlotogorski A, Gordon D, et al,. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 2007; 80: 316-328.
12. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M, National Alopecia Areata Registry. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 2010; 62: 525-527.
13. Arnold L,. Dermatology. In:, Levenson JL, ed. Essentials of Psychosomatic Medicine. American Psychiatric Publishing, Washington, DC, 2007: 237-260.
14. García-Hernández MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F,. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999; 26: 625-632.
15. Picardi A, Pasquini P, Cattaruzza MS, et al,. Psychosomatic factors in first-onset alopecia areata. Psychosomatics 2003; 44: 374-381.
16. Güleç AT, Tanriverdi N, Dürü C, Saray Y, Akçali C,. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-356.
17. Colon EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK,. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Comp Psychiatry 1991; 32: 245-251.
18. Ghajarzadeh M, Ghiasi M, Kheirkhah S,. Depression and quality of life in Iranian patients with Alopecia Areata. Iran J Dermatol 2011; 14: 140-143.
19. Ware JE, Sherbourne CD,. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
20. Ware JE,. SF-36 Health Survey Update. Spine 2000; 25: 3130-3139.
21. The SF-36 Health survey (original version) language recalls. Serbian version. URL: http://www.qualitymetric.com (last accessed 20 July 2015).
22. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for simple use. Clin Exp Dermatol 1994; 19: 210-216.
23. Dermatology Life Quality Index (DLQI) Serbian version. URL: http://www.cardiff.ac.uk/dermatology/quality-of-life/dermatology-quality-of-life-index-dlqi/dlqi-different-language-versions/ (last accessed 20 July 2015).
24. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ,. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
25. Jankovic S, Raznatovic M, Marinkovic J, et al,. Health-related quality of life in patients with psoriasis. J Cutan Med Surg 2011; 15: 29-36.
26. Sojevic Timotijevic Z, Jankovic S, Trajkovic G, et al,. Identification of psoriatic patients at risk of high quality of life impairment. J Dermatol 2013; 40: 797-804.
27. Maksimovic N, Jankovic S, Marinkovic J, Sekulovic LK, Živkovic Z, Spiric VT,. Health-related quality of life in patients with atopic dermatitis. J Dermatol 2012; 39: 42-47.
28. Milobratovic D, Jankovic S, Vukičevic J, Marinkovic J, Jankovic J, Railic Z,. Quality of life in patients with toenail onychomycosis. Mycoses 2013; 56: 543-551.
29. Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y,. Concepts of patients with alopecia areata about their disease. BMC Dermatology 2005; 5: 1.
30. De Hollanda TR, Sodre CT, Brasil MA, Ramos-e-Silva M,. Qualiy of life in alopecia areata: a case-control study. Int J Trichology 2014; 6: 8-12.
31. Cartwright T, Endean N, Porter A,. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol 2009; 160: 1034-1039.
32. Hirsso P, Rajala U, Laakso M, Hiltunen L, Härkönen P, Keinänen-Kiukaanniemi S,. Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population based study. Health Qual Life Outcomes 2005; 3: 49.
33. Reid EE, Haley AC, Borovicka JH, et al,. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol 2012; 66: e97-e102.
34. Bilgiç Ö, Bilgiç A, Bahalbox drawings light down and left K, Bahali AG, Gürkan A, Ybox drawings light down and leftlmaz S,. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol 2014; 28: 1463-1468.